Donanemab in Early Symptomatic Alzheimer Disease
2023 · JAMA · 2,176 citations
https://doi.org/10.1001/jama.2023.13239
S
Stephen Thein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
3.7K
Citations
16
h-index
16
i10-index
Stephen Thein is an academic researcher. The author has contributed to research in topics: Alzheimer's disease research and treatments & Sleep and Wakefulness Research & Dementia and Cognitive Impairment Research. The author has an h-index of 16, co-authored 27 publications.
Papers by this author
worksTargeting Prodromal Alzheimer Disease With Avagacestat
2015 · JAMA Neurology · 230 citations
https://doi.org/10.1001/jamaneurol.2015.0607
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Xp13512/Gsk1838262 in the Treatment of Patients With Primary Restless Legs Syndrome
2009 · SLEEP · 72 citations
https://doi.org/10.1093/sleep/32.2.159
The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial
2023 · American Journal of Respiratory and Critical Care Medicine · 70 citations
https://doi.org/10.1164/rccm.202306-1036oc
EVIDENCE AGAINST THE ROLE OF CHROMOSOMES 17P AND 5Q IN EARLY COLORECTAL CARCINOGENESIS
1988 · Oxford University Research Archive (ORA) (University of Oxford) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat